Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
Pharmtech & Ingredient...Pharmtech & Ingredients
Not Confirmed
Not Confirmed
19-22 November, 2024
Rescon USA SummitRescon USA Summit
Not Confirmed
Not Confirmed
21-22 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Pharmtech & Ingredient...Pharmtech & Ingredients
Industry Trade Show
Not Confirmed
19-22 November, 2024
Rescon USA SummitRescon USA Summit
Industry Trade Show
Not Confirmed
21-22 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/lgm-pharma-has-made-significant-strides-in-meeting-the-evolving-needs-of-its-clients
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/chinese-fda-registered-generic-facilities-gain-steam-india-maintains-lead-with-396-facilities
15 Aug 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/regenerx-effects-reverse-stock-split-and-terminates-sec-reporting-obligations-301900639.html
07 Aug 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/regenerx-receives-stockholder-approval-for-reverse-stock-split-301895000.html
01 Aug 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/regenerx-to-extend-consent-solicitation-vote-301890689.html
13 Apr 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/first-patient-enrolled-into-us-phase-3-neurotrophic-keratitis-clinical-trial-with-rgn-259-301796701.html
11 Apr 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/regenerx-issues-letter-to-stockholders-301794921.html
03 Jan 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/publication-of-rgn-259-phase-3-clinical-trial-results-in-patients-with-neurotrophic-keratopathy-301712318.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?